866-997-4948(US-Canada Toll Free)

Genomics And Proteomics Reagents, Research Kits and Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency Market Research

Published Date : Aug 2013

Category :

Biotechnology

No. of Pages : 115 Pages


Genomics and proteomics have greatly increased the volume and quality of information with regards to several lesser known genetic diseases and as such have expedited the cure for many illnesses. The market report encompasses the various technologies that account for genomics and proteomics research by various end users such as drug discovery and development, life-science research such as disease identification and diagnostics. The stakeholders for this study include market players who manufacture reagents and research kits, analytical tools and other products used in genomics and proteomics research.

The market accounts for commercialized ready-to-use research kits to carry out various processes such as isolation, purification, labeling probes, electrophoresis, chromatography, polymerase chain reactions. The study also accounts for specialized analytical tools for proteomics and genomics such as chromatography, mass spectrometry, next generation sequencing and thermal cyclers for PCR reactions. The study details the market dynamics and trends such as the drivers, restraints and opportunities that shape the commercialization of this field. Several other impact factors such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been elucidated in the study in order to give a thorough analysis of the competitive scenario and potential areas in the market.

The report also studies four major geographies of North America, Europe, Asia-Pacific and Rest of the World. A PESTLE analysis has been carried out in order to estimate the current status and future growth potential for these products independently. The global scenario gives a summation of the impact of political, economical, social, technological, legal and environmental factors affecting the growth of this market. The report profiles 14 market players that are currently the most popular sources for the tools and techniques to conduct life-science research. The report also delivers several recommendations throughout the report for potential areas for investment, growth and expansion of businesses.

The global genomics and proteomics market is segmented into the following categories:

Genomics and Proteomics Market, by Reagent and Research Kits
  • Sample Preparation Kits
  • Prepackaged Sample Preparation Kits for PCR
  • Prepackaged Sample Preparation Kits for Chromatography
  • Prepackaged Sample Preparation Kits for Mass Spectrometry
  • Prepackaged Sample Preparation Kits for  Electrophoresis
  • Purification Kits
  • Electrophoresis Kits
  • Capillary Electrophoresis/li>
  • Gel Electrophoresis
  • BioChips and Microarrays
  • DNA BioChips and Microarrays
  • Protein and Peptide BioChips and Microarrays

Genomics and Proteomics Market, by Analytical Instruments 
  • Chromatography
  • Gas Chromatography
  • Liquid Chromatography
  • Mass Spectrometry, by Analyzers
  • Tandem Mass Spectrometry
  • Time-Of-Flight Mass Spectrometry
  • Quadrupole Mass Spectrometry
  • Fourier Transform Mass Spectrometry
  • Others(Magnetic Sector, Orbitrap, Ion Trap)
  • Thermal Cyclers
  • Digital Thermal Cyclers
  • Conventional or Traditional Thermal Cyclers
  • Real-Time Thermal Cyclers
  • Next Generation Sequencing

Genomics and Proteomics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Table of Content

Chapter 1 Preface
1.1 ReportDescription
1.2 Market Segmentation: Genomics & Proteomics
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.4 Assumptions And Stipulations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Genomics and Proteomics Market

Chapter 3 Global Genomics and Proteomics Market Overview
3.1 Genomics and Proteomics Industry Overview and Milestones
3.2 Applications of Genomics and Proteomics Technologies
3.2.1 Agriculture and Animal Husbandry
3.2.2 Drug Discovery
3.2.3 Forensics
3.2.4 Proteogenomics Research
3.2.5 Disease Identification, Diagnostics and Control
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Drug Discovery and Disease Identification a Strong Driver
3.3.1.2 Increased Investment in Healthcare and Medical Research by Developing Countries
3.3.1.3 Software and Service Sector in Genomics and Proteomics is Booming
3.3.2 Restraints
3.3.2.1 Low Adoption and Penetration in Developing Countries due to Cost of Technology
3.3.2.2 Highly Fragmented Market may Increase Volume but is Expected to Reduce in Terms of Revenue
3.3.3 Opportunities
3.3.3.1 Collaboration for Research with Research Facilities in Developing Countries
3.4 Market Attractiveness for Genomics and Proteomics Market, by Geography
3.5 Porters Five Forces Analysis for Genomics and Proteomics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from Substitutes
3.5.4 Threat from New Entrants
3.5.5 Degree of Competitive Rivalry

Chapter 4 Global Genomics and Proteomics Reagents and Research Kits Market
4.1 Sample Preparation Kits Market
4.1.1 Global Sample Preparation Kits Market, By Segments, 2011 - 2019 (USD Million)
4.1.2 Prepackaged Sample Preparation for Polymerase Chain Reaction
4.1.3 Prepackaged Sample Preparation for Mass Spectrometry
4.1.4 Prepackaged Sample Preparation for Chromatography
4.1.5 Prepackaged Sample Preparation for Electrophoresis
4.2 Purification Reagent Kits
4.2.1 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
4.2.2 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3 Electrophoresis Kits
4.3.1 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3.2 Capillary Electrophoresis
4.3.3 Gel Electrophoresis
4.4 Biochips and Microarrays
4.4.1 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
4.4.2 DNA Microarrays
4.4.3 Protein and Peptide Microarrays

Chapter 5 Global Genomics and Proteomics Analytical Tools Market, by Technologies, 2011 - 2019 (USD Million)
5.1 Chromatography
5.1.1 Global Chromatography Market, by Types, 2011 - 2019 (USD Million)
5.1.2 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
5.1.3 Gas Chromatography
5.1.4 Liquid Chromatography
5.1.4.1 High Performance Liquid Chromatography
5.1.4.2 Ultra High Performance Chromatography
5.2 Mass Spectrometry
5.2.1 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
5.2.2 Tandem Mass Spectrometry
5.2.3 Quadrupole Mass Spectrometry
5.2.4 Fourier Transform Mass Spectrometry
5.2.5 TOF Mass Spectrometry
5.2.6 Other Mass Spectrometry Analyzers
5.3 Thermal Cyclers
5.3.1 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
5.3.2 Digital PCR Thermal Cyclers
5.3.3 Conventional or Traditional Thermal Cyclers
5.3.4 Real-Time PCR Thermal Cyclers
5.4 Next Generation Sequencing
5.4.1 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)

Chapter 6 Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.1 Introduction
6.1.1 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.2 North America
6.2.1 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.5 Rest of the World
6.5.1 Row Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)

Chapter 7 Market Share Analysis of Key Players, 2012
7.1 Market Share Analysis of Key Players, 2012 (%)

Chapter 8 Company Profiles
8.1 Affymetrix
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Becton Dickinson & Company
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Bio-Rad
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Bruker Corporation
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Danaher Corporation
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.7 Illumina, Inc.
8.7.1 Business Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Business Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Merck Millipore
8.9.1 Business Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Myriad Genetics, Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Perkinelmer
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Qiagen
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
8.13 Shimadzu Biotech
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Sigma Aldrich Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Thermo Fisher Scientific
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies

List of Table


TABLE 1 Market Snapshot: Global Genomics and Proteomics Market
TABLE 2 Global Sample Preparation Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 3 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 4 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 5 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 6 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
TABLE 7 Global Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 8 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
TABLE 9 Global Liquid Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 10 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
TABLE 11 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
TABLE 12 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)
TABLE 13 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
TABLE 14 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 15 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 16 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 17 ROW Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)

List of Chart


FIG. 1 Genomics & Proteomics Market Segmentation
FIG. 2 Global Genomics and Proteomics Market, by Segments, 2012 (USD Million)
FIG. 3 Market Attractiveness for Genomics and Proteomics Market, by Geography
FIG. 4 Porter’s Five Forces Analysis for Genomics and Proteomics Market
FIG. 5 Global Sample Preparation Kits Market for PCR, 2011-2019 (USD Million)
FIG. 6 Global Sample Preparation Kits Market for Mass Spectrometry, 2011-2019 (USD Million)
FIG. 7 Global Sample Preparation Kits Market for Chromatography, 2011-2019 (USD Million)
FIG. 8 Global Sample Preparation Kits Market for Electrophoresis, 2011-2019 (USD Million)
FIG. 9 Global Capillary Electrophoresis Market, 2011-2019 (USD Million)
FIG. 10 Global Gel Electrophoresis Market, 2011-2019 (USD Million)
FIG. 11 Global DNA Microarrays Market, 2011-2019 (USD Million)
FIG. 12 Global Protein and Peptide Microarrays Market, 2011-2019 (USD Million)
FIG. 13 Global Gas Chromatography Market, 2011-2019 (USD Million)
FIG. 14 Global Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 15 Global High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 16 Global Ultra High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 17 Global Tandem Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 18 Global Quadrupole Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 19 Global Fourier Transform Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 20 Global Time-Of-Flight Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 21 Global Other Mass Spectrometers Market, 2011-2019 (USD Million)
FIG. 22 Global Digital Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 23 Global Conventional or Traditional Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 24 Global Real-Time Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 25 Global Next Generation Sequencers Market, 2011-2019 (USD Million)
FIG. 26 North America Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 27 Europe Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 28 Asia-Pacific Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 29 Rest of the World Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 30 Global Genomics and Proteomics Market Share Analysis of Key Players, 2012 (%)
FIG. 31 Affymetrix: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 32 Agilent Technologies: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 33 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 34 Bio-Rad: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 35 Bruker Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 36 Danaher Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 37 Illumina, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 38 Life Technologies Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 39 Merck Millipore: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 40 Myriad Genetics, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 41 Perkinelmer: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 42 Qiagen: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 43 Shimadzu Biotech: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 44 Sigma Aldrich: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 45 Thermo Scientific Fisher: Annual Sales Revenue, USD Million, 2010 – 2012

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *